2019
DOI: 10.2174/1871520618666180830162517
|View full text |Cite
|
Sign up to set email alerts
|

Protective Effects of Downregulating Estrogen Receptor Alpha Expression in Cervical Cancer

Abstract: Downregulating ER-α expression may be a potential treatment regimen for cervical cancer patients and will be of great significance for patients with cervical cancer who are receiving conventional treatment for nonsurgical treatments.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 0 publications
0
5
0
Order By: Relevance
“…In vivo studies by Chung and Lambert (2009) suggested that estrogen might be involved in the carcinogenesis of CC. Epidemiological data ( Chung et al, 2010 ; Bronowicka-Kłys et al, 2016 ; Yu et al, 2018 ) also confirmed that women with the highest serum estrogen levels had an increased risk of CC. Therefore, estrogen might be another potential mechanism mediated by the gut microbiota affecting CC.…”
Section: Discussionmentioning
confidence: 75%
“…In vivo studies by Chung and Lambert (2009) suggested that estrogen might be involved in the carcinogenesis of CC. Epidemiological data ( Chung et al, 2010 ; Bronowicka-Kłys et al, 2016 ; Yu et al, 2018 ) also confirmed that women with the highest serum estrogen levels had an increased risk of CC. Therefore, estrogen might be another potential mechanism mediated by the gut microbiota affecting CC.…”
Section: Discussionmentioning
confidence: 75%
“…It may also be indicated that ERα and ERβ regulate processes connected with the female reproductive system in regulating several other physiological and pathophysiological processes in the human body. Disrupted ER signaling leads to the development of different diseases, such as osteoporosis, neurodegeneration, inflammation and metabolic and cardiovascular diseases [ 19 ]; however, the most important indications to modify their activity connected with estrogen-related cancers such as breast [ 19 ], endometrial [ 20 ], cervical [ 21 ] and ovarian cancer [ 22 ].…”
Section: Resultsmentioning
confidence: 99%
“…This is because more than half of breast cancers are ERα overexpressing, and about 70% of them respond to antiestrogen therapy (for example, tamoxifen). On the other hand, an increased expression of ERα and ERβ in benign breast epithelium seems to indicate an increased risk of breast cancer, suggesting a role for ERα in breast cancer initiation and progression [ 19 , 21 ].…”
Section: Resultsmentioning
confidence: 99%
“…It is now recognized that ERa is a key regulator of energy homeostasis and glucose metabolism and that the ERa pathway might represent a potential therapeutic target for the prevention or treatment of insulin resistance, type 2 diabetes mellitus, and non-alcoholic fatty liver diseases [16,32]. On the other hand, ERa is linked with a variety of cancers and metastases, including breast cancer, cervical cancer, lung carcinoma, and prostate cancer [33][34][35][36].…”
Section: Eramentioning
confidence: 99%